Search Result "hypusine modification inhibitor"
Hypusine Modification of the Ribosome-binding Protein eIF5A, a Target for New Anti-Inflammatory Drugs: Understanding the Action of the Inhibitor GC7 on a Murine Macrophage Cell Line
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 2 Year: 2014 Page: 284-292
Author(s): Oedem Paulo de Almeida Jr, Thais Regina Toledo, Danuza Rossi, Daniella de Barros Rossetto, Tatiana Faria Watanabe, Fabio Carrilho Galvao, Alexandra Ivo Medeiros, Cleslei Fernando Zanelli, Sandro Roberto Valentini
Inhibition of Hypusine Biosynthesis in Plasmodium: A Possible, New Strategy in Prevention and Therapy of Malaria
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 6 Issue: 1 Year: 2006 Page: 1231-1241
Author(s): A. Kaiser, D. Ulmer, T. Goebel, U. Holzgrabe, M. Saeftel, A. Hoerauf
Targeting Polyamine Metabolism for Finding New Drugs Against Leishmaniasis: A Review
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 15 Issue: 3 Year: 2015 Page: 243-252
Author(s): Andrea Ilari,Annarita Fiorillo,Paola Baiocco,Elena Poser,Gabriella Angiulli,Gianni Colotti
Thirty Years of Polyamine-Related Approaches to Cancer Therapy. Retrospect and Prospect. Part 1. Selective Enzyme Inhibitors
Journal: Current Drug Targets
Volume: 4 Issue: 7 Year: 2003 Page: 537-564
Author(s): Nikolaus Seiler
Polyamine Transport and Synthesis in Trichomonas vaginalis: Potential Therapeutic Targets
Journal: Current Pharmaceutical Design
Volume: 23 Issue: 23 Year: 2017 Page: 3359-3366
Author(s): Maria Elizbeth Alvarez-Sanchez,Jose Luis Villalpando,Laura Itzel Quintas-Granados,Rossana Arroyo
Alpha-Interferon and Its Effects on Signalling Pathways Within Cells
Journal: Current Protein & Peptide Science
Volume: 5 Issue: 6 Year: 2004 Page: 475-485
Author(s): Michele Caraglia, Giovanni Vitale, Monica Marra, Alfredo Budillon, Pierosandro Tagliaferri, Alberto Abbruzzese
α-Methylated Polyamines as Potential Drugs and Experimental Tools in Enzymology
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 7 Issue: 8 Year: 2007 Page: 813-820
Author(s): Tuomo A. Keinanen, Aki Jarvinen, Anne Uimari, Jouko Vepsalainen, Alex R. Khomutov, Nikolay A. Grigorenko, Mervi T. Hyvonen, Marc Cerrada-Gimenez, Leena Alhonen, Juhani Janne
The HAG Mechanism: A Molecular Rationale For The Therapeutic Application Of Iron Chelators In Human Diseases Involving the 2-Oxoacid Utilizing Dioxygenases
Journal: Current Medicinal Chemistry
Volume: 10 Issue: 1 Year: 2003 Page: 1005-1019
Author(s): Hartmut M. Hanauske-Abel, Anthony M. Popowicz
Editorial (Thematic Issue: Mitochondria and Subcellular Organelles as Treatment Targets Against Pathological Conditions)
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 2 Year: 2014 Page: 153-154
Author(s): Antonio Toninello
Emerging Strategies to Strengthen the Anti-Tumour Activity of Type I Interferons: Overcoming Survival Pathways
Journal: Current Cancer Drug Targets
Volume: 9 Issue: 5 Year: 2009 Page: 690-704
Author(s): M. Caraglia, M. Marra, P. Tagliaferri, S. W.J. Lamberts, S. Zappavigna, G. Misso, F. Cavagnini, G. Facchini, A. Abbruzzese, L. J. Hofland, G. Vitale